CE2 HEALTH ECONOMIC ASSESSMENT OF THE ATAC TRIAL COMPARING ANASTROZOLE VERSUS TAMOXIFEN IN ADJUVANT TREATMENT OF POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER
Nov 1, 2003, 00:00 AM
10.1016/S1098-3015(10)61604-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)61604-X/fulltext
Section Title :
Section Order :
51
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61604-X&doi=10.1016/S1098-3015(10)61604-X